RB1 and systemic lupus erythematosus: Then, the effects of SLE on the pharmacokinetics of ginsenoside Rb2, Rc, Rg2, Rg3, Rd and Rb1 were thoroughly investigated based on in vitro and in vivo models, and SLE was found can greatly enhance the exposure of ginsenoside Rb2, Rc, Rg2, Rg3, Rd and Rb1 in cells and rats.